June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Correlation of structural and visual function tests in patients with diabetic macular edema
Author Affiliations & Notes
  • Elizabeth Pearce
    Ophthalmology, King's College Hospital, London, United Kingdom
  • Raeba Mathew
    Ophthalmology, King's College Hospital, London, United Kingdom
  • Ahmed Abdel-hay
    Ophthalmology, King's College Hospital, London, United Kingdom
  • Sobha Sivaprasad
    Ophthalmology, King's College Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships Elizabeth Pearce, Novartis (R); Raeba Mathew, Allergan (R), Novartis (R); Ahmed Abdel-hay, None; Sobha Sivaprasad, Allergan (F), Bayer (F), Novartis (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4924. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elizabeth Pearce, Raeba Mathew, Ahmed Abdel-hay, Sobha Sivaprasad; Correlation of structural and visual function tests in patients with diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4924.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: There is sufficient evidence to suggest that visual acuity does not correlate with macular thickness in patients with diabetic macular edema (DME). It is unclear whether other visual function tests would correlate with the central subfield thickness (CSF) as measured by spectral domain optical coherent topography. In this study, we assessed the correlation of various visual function tests in DME with CSF

Methods: This is a prospective study on 22 eyes of diabetic patients with centre-involving macular edema. Best corrected visual acuity (BCVA), contrast sensitivity (Pelli Robson letter score) and foveal and retinal sensitivity measured by microperimetry (Nidek MP1) were recorded. Maximum reading speed (MRS) was evaluated using MNRead acuity charts. The central subfield thickness (CST) was performed using a standard protocol on the Heidelberg Spectralis SD-OCT. The Pearson correlation coefficient (r) was used to measure the linear association between visual function test score and between these scores and OCT-measured CST. P < 0.05 was considered statistically significant.

Results: The correlation coefficient for the association between CSF and BCVA was -0.273 (p=0.219), contrast sensitivity was 0.095 ( p-value 0.673), MRS was 0.344 (p-value 0.116), foveal sensitivity was -0.365 (p-value 0.095) and retinal sensitivity was -0.271 (p-value 0.223). On the basis of multivariate regression models, none of these visual function parameters were significantly associated (P<0.05, after adjusting for multiple testing) with CST.

Conclusions: In DME, the combination of MRS, retinal senstivitiy and visual acuity score is advocated to provide a more comprehensive assessment of retinal function. However, none of these tests correlated with CST suggesting that CST is not an appropriate measure to assess structure-function correlation in DME.

Keywords: 499 diabetic retinopathy • 498 diabetes • 505 edema  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×